Skip to main content

Lumryz

Pronunciation: LOOM rize
Generic name: sodium oxybate
Dosage form: granules for extended-release oral suspension (4.5 g, 6 g, 7.5 g, 9 g.)
Drug class: Miscellaneous anxiolytics, sedatives and hypnotics

Medically reviewed by Melisa Puckey, BPharm. Last updated on Oct 30, 2024.

What is Lumryz? 

Lumryz (sodium oxybate) is a prescription medicine used to treat cataplexy and excessive daytime sleepiness (EDS) caused by narcolepsy, in patients that are 7 years and older. Lumryz helps to improve the quality and quantity of deep sleep at night, which may reduce excessive daytime sleepiness and the number of sleeping periods during the day and improve cataplexy. Lumryz is a central nervous system depressant.

Lumryz mechanism of action (MOA) is thought to be activating the GABA-B receptor, which may improve sleep by increasing the time spent in the sleep stages (N2 and N3) and decreasing the shift to stages N1/Wake/REM, which results in deeper sleep. The active ingredient is sodium oxybate, the sodium salt of gamma-hydroxybutyrate (GHB), a known street drug of abuse.

What is Lumryz used to treat?

Lumryz FDA approval was received on May 01, 2023, it is now indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy. Narcolepsy is a chronic neurological disorder that affects the brain's ability to control sleep-wake cycles.

Excessive daytime sleepiness is characterized by persistent sleepiness where an overwhelming sense of sleepiness comes on quickly. Cataplexy is characterized by a sudden onset of weak or paralyzed muscles.

Is Lumryz a controlled substance?

Yes, Lumryz is a Schedule III controlled substance (CIII) , which means it has a potential for abuse less than substances in Schedules 1 and 2, and it has an accepted medical use in treatment in the United States. Abuse of Lumryz may lead to moderate or low physical dependence or high psychological dependence.

Lumryz REMS program

Lumryz is only available through the Lumryz ​​REMS (Evaluation and Mitigation Strategy) program due to the potential for abuse and the risk of the serious side effects of significant CNS and respiratory depression. The REMS program goal is to reduce the risks of serious adverse outcomes resulting from inappropriate prescribing, misuse, abuse, and diversion. 

The patient receiving the prescription must read all relevant material, receive counseling from the prescriber, fill out the Lumryz Patient Enrollment Form, and fill out the Patient Counseling Checklist with the pharmacist. You must be registered in the program and understand the risks and benefits of this medicine. The Lumryz REMS programs require the prescriber and dispensing pharmacists to be certified and follow all guidelines. 

If you have any questions, ask your doctor or call the Lumryz REMS at 1-877-453-1029.

Lumryz side effects

Common Lumryz side effects

The most common Lumryz side effects include nausea, dizziness, bedwetting, headache, and vomiting. Side effects may increase when taking higher doses, these side effects occurred in 5% or more of adult patients.

The most common Lumryz side effects in children for immediate-release sodium oxybate were nausea, bedwetting, vomiting, headache, weight decrease, decreased appetite, dizziness, and sleepwalking. These side effects occurred in 5% or more of patients.

 Serious Lumryz side effects 

Lumryz can cause serious side effects, including:

Also, see the warning section.

These are not all the possible side effects. For more information, ask your doctor or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA1088.

Warnings

Lumryz is a central nervous system (CNS) depressant. Taking Lumryz with other CNS depressants such as medicines used to make you fall asleep, including opioid analgesics, benzodiazepines, sedating antidepressants, antipsychotics, sedating anti-epileptic medicines, general anesthetics, muscle relaxants, alcohol, or street drugs, may cause serious medical problems, including:

Ask your doctor if you are not sure if you are taking a medicine listed above.

Lumryz is a federal controlled substance (CIII). The active ingredient of Lumryz is a form of gamma-hydroxybutyrate (GHB) that is also a federal controlled substance (CI). Abuse of illegal GHB, either alone or with other CNS depressants may cause serious medical problems, including:

Call your doctor right away if you have any of these serious side effects.

Anyone who takes this medicine should not do anything that requires them to be fully awake or is dangerous, including driving a car, using heavy machinery, or flying an airplane, for at least 6 hours after taking a dose. Those activities should not be done until you know how the medicine affects you.

Keep this medicine in a safe place to prevent abuse and misuse. Selling or giving away this medicine may harm others and is against the law. Tell your doctor if you have ever abused or been dependent on alcohol, prescription medicines, or street drugs.

Because of the risk of CNS depression, abuse, and misuse, Lumryz is available only by prescription and filled through certified pharmacies in the Lumryz REMS.

Who should not take Lumryz?

You should not take this medicine if you:

What should I tell my doctor before taking Lumryz?

Before you start treatment, tell your doctor about all medical conditions, including if you:

Pregnancy

Tell your doctor if you are pregnant or plan to become pregnant. It is not known if this medicine can harm your unborn baby.

Breastfeeding

Tell your doctor if you are breastfeeding or plan to breastfeed. Lumryz passes into breast milk. You and your doctor should decide if you will take Lumryz or breastfeed.

How should I take Lumryz?

Dosing information

Lumryz  Dose for Adults Narcolepsy

Initiate dosage at 4.5 g once per night orally. Titrate to effect in increments of 1.5 g per night at weekly intervals.
Recommended dosage range: 6 g to 9 g once per night orally.

Use:
- treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy.

Lumryz Dose Pediatric Patients (7 Years of Age and Older)

The recommended starting dosage, titration regimen, and maximum total nightly dosage are based on body weight 

Pediatric patients weighing 45 kg or greater (7 Years and older)

Initiate dosage at 4.5 g once per night orally. Increase dose, depending on effect, in increments of 1.5 g per night at weekly intervals to the maximum recommended dosage of 9 g once per night orally. The dosage may be gradually titrated based on efficacy and tolerability

Pediatric patients weighing less than 45 kg (7 Years and older)

Because the recommended starting dosage cannot be achieved with the available strengths of Lumryz use another sodium oxybate product to initiate treatment.

Important General Administration Information

Lumryz is available in packets of 4.5 g, 6 g, 7.5 g, or 9 g.

What other drugs will affect Lumryz?

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Especially, tell your doctor if you take other medicines to help you sleep (sedatives) or that may make you sleepy, such as some medicines to treat pain, anxiety, depression, or seizures.

Know the medicines you take. Keep a list of them to show your doctor and pharmacist when you get a new medicine.

Does Lumryz interact with my other drugs?

Enter medications to view a detailed interaction report using our Drug Interaction Checker.

Storage

Keep all medicines out of the reach of children and pets.

Lumryz Prescribing Information

Review the Lumryz Prescribing Information for more detailed information about this medicine. Discuss any medical questions you have with your doctor or other health care provider. This is not all the information you need to know about this medicine for safe and effective use, and it does not take the place of talking to your doctor about your treatment.

Prescribing Information (PI) Package Insert is sometimes called  Lumryz Package Insert  or FDA label.

What are the ingredients in Lumryz?

Active ingredients: sodium oxybate
Inactive ingredients: carrageenan, hydrogenated vegetable oil, hydroxyethyl cellulose, magnesium stearate, malic acid, methacrylic acid copolymer, microcrystalline cellulose, povidone, xanthan gum.

Instructions for Use

Important information

Before using Lumryz

Before each Use

Gather the following supplies and place them on a flat surface at your bedside:

Mix the Lumryz solution at your bedside

  1. At your bedside, open the mixing cup by twisting the cap to the left (counter-clockwise) to remove it.
  2. Fill the mixing cup with water up to Fill Line A (top line) and set the mixing cup down on a flat surface.
  3. Open 1 packet:
    Use scissors to cut open the packet along the Cutting Line, located on the back of the packet
    or
    Fold the packet in half at the gray Tear Mark located on the back of the packet. Tear the packet open with your hands. 
  4. Pour the entire content from the packet into the water-filled mixing cup.
    Make sure there is no powder left in the packet.
  5. Close the mixing cup by twisting the cap to the right (clockwise) until firmly closed.
  6. Mix the water and powder solution by shaking the closed mixing cup well for at least 60 seconds (1 minute).
  7. Make sure the solution is mixed thoroughly.
    The mixed solution will appear slightly milky with some lumps.
    The mixing cup cap is not child resistant. If the mixed solution is not taken immediately, then do not remove the cap, and keep out of reach of children.

Take the Lumryz solution at your bedside

  1. Open the mixing cup by twisting the cap to the left (counter-clockwise) and remove it.
  2. While sitting in bed drink the mixed solution within 30 minutes of mixing. 
    Make sure to drink all the mixed solution in the mixing cup.
  3. Immediately refill your mixing cup with water up to Fill Line B (lower line) to mix in any medicine left in the mixing cup.
    Do not open another packet. Take only 1 packet each day at bedtime.
  4. Close the mixing cup by twisting the cap to the right (clockwise) until firmly closed.
  5. Shake well again for 10 seconds.
  6. Open the mixing cup by twisting the cap to the left (counter-clockwise) and remove it.
  7. Drink the mixed solution immediately after mixing. 
    Make sure to drink all the mixed solution in the mixing cup.
  8. Leave the empty mixing cup at your bedside and immediately lie down to go to sleep. 
    Avoid getting out of your bed after taking your dose.

How do I throw away (dispose of) Lumryz?

  1. The next day, place the empty packet in the trash.
    If any Lumryz remains in the packet, rinse it down the sink prior to disposal.
  2. Empty any unused Lumryz down the sink drain the next day.
    Clean the mixing cup by rinsing it with water and letting it dry before each use.

After you finish all of the packets in your Lumryz carton

After you have finished your last packet in the carton, throw away the rinsed mixing cup in the trash.

Company 

Distributed By: Avadel CNS Pharmaceuticals, LLC Chesterfield, MO 63005

Popular FAQ

What is the difference between Lumryz vs Xyrem?

Both Xyrem and Lumryz are medications used to treat narcolepsy, but they have some key differences. Although Xyrem and Lumryz contain the same active ingredient, sodium oxybate (also known as gamma-hydroxybutyrate or GHB), there are differences in how they are taken. Continue reading

What is Lumryz REMS?

Lumryz REMS refers to the safety program through which Lumryz can be prescribed by a doctor and through which Lumryz can be dispensed to a patient. REMS stands for Risk Evaluation and Mitigation Strategy and Lumryz REMS is required by the FDA (Food and Drug Administration) to ensure the potential benefits of Lumryz outweigh its risks. Continue reading

How does Xyrem work for narcolepsy?

Xyrem's mechanism of action for narcolepsy is thought to involve binding to GABAB and GHB receptors which enhances delta wave activity, improving the quality and quantity of deep sleep; however, the exact way it works is unknown. Continue reading

Is Xyrem a controlled substance / narcotic drug of abuse?

Yes, Xyrem is a controlled substance, and has a high potential to be abused. Xyrem contains sodium oxybate, also known as GHB, which is a known street drug of abuse. Xyrem is not a narcotic, the active ingredient sodium oxybate, is a central nervous system depressant. Continue reading

What is Xyrem REMS?

Xyrem REMS refers to the program through which Xyrem can be prescribed by a doctor and through which Xyrem can be dispensed to a patient. Continue reading

How much sodium is in Xyrem?

Xyrem has a high salt content (salt is also known as sodium). People with heart failure, high blood pressure, kidney disease, or on a low salt diet should consider how much salt (sodium) is in each dose of Xyrem. Continue reading

Can you take Xyrem while pregnant?

Xyrem is not recommended during pregnancy because it readily crosses the placenta. Xyrem is a central nervous system (CNS) depressant that slows down brain activity, which may be detrimental to a developing baby. Xyrem should not be given to pregnant women unless the perceived benefits far outweigh the risks. Continue reading

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.